- Description
- Benefits
- Risks
- Additional information
- Research
Description
Ipamorelin is a selective synthetic pentapeptide belonging to the class of growth hormone releasing peptides (GHRPs). It is widely studied in laboratory environments for its role in growth hormone (GH) secretion, ghrelin receptor activation, and endocrine signalling pathways.
In controlled research settings, Ipamorelin functions as a highly selective agonist of the growth hormone secretagogue receptor (GHS-R), stimulating endogenous growth hormone release from the pituitary gland while maintaining a focused interaction within GH-related pathways.
Due to its selectivity, Ipamorelin is commonly investigated in research models exploring precise hormonal regulation, metabolic signalling, and neuroendocrine pathway control.
Across Ireland and Europe, Ipamorelin is frequently used in studies involving:
- Growth hormone secretion and regulation
- Ghrelin receptor (GHS-R) activation
- Endocrine and neuroendocrine system research
- Metabolic and energy regulation pathways
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – Ipamorelin
| Specification | Details |
|---|---|
| Product Name | Ipamorelin |
| Compound Type | Synthetic pentapeptide |
| Functional Class | Growth hormone releasing peptide (GHRP) |
| Mechanism of Action | Selective ghrelin receptor (GHS-R) agonist |
| Biological Targets | Pituitary gland, GHS-R receptors |
| Amino Acid Length | 5 amino acids |
| Format | Lyophilised powder |
| Purity | Research-grade (high purity) |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Further Refrences: PubChem Entry
Researched Benefits & Focus Areas – Ipamorelin
1. Selective Growth Hormone (GH) Release Research
Ipamorelin has been studied for:
- Targeted stimulation of endogenous GH release
- Investigation of pituitary gland signalling pathways
- Analysis of controlled hormonal secretion patterns
Reference basis: Derived from endocrinology and pharmacology research examining selective GHRP activity and receptor-specific activation.
2. Ghrelin Receptor (GHS-R) Activation
Research has explored:
- Binding to growth hormone secretagogue receptors
- Targeted activation of ghrelin signalling pathways
- Reduced interaction with non-target biological systems (research context)
Reference basis: Based on biochemical studies investigating receptor selectivity in peptide-receptor interactions.
3. Endocrine System Precision & Regulation
Ipamorelin is used in:
- Research into precise hormonal modulation
- Investigation of the GH/IGF-1 axis
- Studies on neuroendocrine signalling systems
Reference basis: Supported by clinical and preclinical studies examining endocrine system regulation and GH pathway control.
4. Metabolic & Energy Regulation Research
- Studied for its role in metabolic signalling pathways
- Explored in energy utilisation and regulation models
- Investigated for interaction with growth-related metabolic systems
Reference basis: Derived from research into ghrelin signalling and metabolic pathway regulation.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – Ipamorelin
1. Hormonal System Influence
- May significantly affect growth hormone levels
- Potential for endocrine imbalance in research models
Reference basis: Based on studies examining GH regulation and endocrine feedback systems.
2. Receptor Interaction Complexity
- May influence multiple signalling pathways
- Potential for variable responses depending on experimental conditions
Reference basis: Derived from research into peptide-receptor binding and signalling complexity.
3. Off-Target Biological Effects
- Possible interaction with non-target systems
- Broad influence across neuroendocrine pathways
Reference basis: Based on studies highlighting interconnected signalling systems.
4. Limited Long-Term Research
- Lack of extensive long-term data
- Primarily studied in controlled laboratory environments
Reference basis: Reflects the current stage of growth hormone peptide research.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
Related Products
Hexarelin 2mg
IGF-1 Long R3 1mg
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS